A detailed history of Wells Fargo & Company transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 35,096 shares of ADGI stock, worth $116,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,096
Previous 680 5061.18%
Holding current value
$116,167
Previous $2,000 5700.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
N/A
34,416 Added 5061.18%
35,096 $116,000
Q1 2024

May 10, 2024

BUY
N/A
6 Added 0.89%
680 $2,000
Q4 2023

Feb 09, 2024

SELL
N/A
-212 Reduced 23.93%
674 $2,000
Q3 2023

Nov 13, 2023

BUY
N/A
14 Added 1.61%
886 $2,000
Q2 2023

Aug 15, 2023

SELL
N/A
-8,774 Reduced 90.96%
872 $2,000
Q1 2023

May 12, 2023

BUY
N/A
8,891 Added 1177.62%
9,646 $31,000
Q4 2022

Feb 13, 2023

SELL
$3.08 - $4.05 $452 - $595
-147 Reduced 16.3%
755 $2,000
Q3 2022

Nov 14, 2022

SELL
$2.97 - $4.83 $994 - $1,618
-335 Reduced 27.08%
902 $2,000
Q2 2022

Aug 12, 2022

SELL
$2.54 - $4.52 $48,158 - $85,699
-18,960 Reduced 93.88%
1,237 $4,000
Q1 2022

May 16, 2022

BUY
$3.81 - $10.77 $3,341 - $9,445
877 Added 4.54%
20,197 $92,000
Q4 2021

Feb 14, 2022

BUY
$6.35 - $47.04 $121,996 - $903,732
19,212 Added 17788.89%
19,320 $140,000
Q3 2021

Nov 15, 2021

BUY
$20.88 - $56.08 $2,255 - $6,056
108 New
108 $5,000

Others Institutions Holding ADGI

About Adagio Therapeutics, Inc.


  • Ticker ADGI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,831,000
  • Market Cap $505M
  • Description
  • Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...
More about ADGI
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.